The nominations for this year's The Pathologist Power List are open.
03/31/2020 | Sponsored by Inspirata
Join this webinar to find out how you can go digital right away at no cost.
03/26/2020 | Sponsored by Thermo Fisher Scientific
Fusion based biomarkers are becoming more and more important in precision oncology clinical research.
03/25/2020 | Sponsored by QIAGEN
The remarkable advances in precision medicine are unfortunately not currently available to all patients, especially those being treated in community cancer settings.
12/09/2019 | Sponsored by Akoya Biosciences
In this webinar, expert speakers from the Fred Hutchinson Cancer Research Center will discuss how they successfully implemented an automated, multiplexed tissue imaging platform for spatial profiling of the TME.
12/05/2019 | Sponsored by Thermo Fisher Scientific
Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.
11/25/2019 | Sponsored by Royal College of Pathologists
To celebrate International Pathology Day 2019, we gathered a panel of experts to discuss the latest in point-of-care testing.
11/21/2019 | Sponsored by Philips
In this Webinar, Dr Juan Retamero, a Pathologist from Granada University Hospitals, Spain, will discuss the efficiency gains they have experienced since the implementation of a digital pathology workflow.
11/05/2019 | Sponsored by Illumina
Recent developments in cancer research, and rapidly increasing options for personalized therapeutics, showed the need for a comprehensive, fast and robust way to analyze the genetic information of DNA and RNA variants.
11/01/2019
Available On Demand
09/25/2019 | Sponsored by Pierian
Comprehensive genomic profiling assays provide extensive coverage of variants and immunotherapy biomarkers and increasingly enable physicians to provide cancer patients with more informed treatments.
09/07/2019 | Sponsored by Bristol-Myers Squibb
Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies.
07/22/2019 | Sponsored by mTuitive
Is your lab ready for inspection? If not, how much time – and how much work – would it take to get there?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
To Screen, or not to Screen?
Women in Pathology
The Matchmakers